Moreover, the flow‐like cytometry plots show that S100A5 was positively expressed mainly in CK19+ tumor cells (58.84%), but almost not in CD4+ T cells (2.45%) or CD8+ T cells (4.15%, Figure 5J). This evidence concerns the gene S100A5 and neoplasm.